This report includes forward-looking statements based on the Company's current
assumptions, expectations and projections about future events. When used in this
report, the words "believes," "anticipates," "may," "expect," "intend,"
"estimate," "project" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking statements contain
such words. In this report, the Company discloses important factors that could
cause actual results to differ materially from management's expectations. For
more information on these and other factors, see "Forward-Looking Information"
herein.

The following Management's Discussion and Analysis of Financial Condition and
Results of Operations should be read in conjunction with "Item 1A. Risk
Factors," and the consolidated financial statements and related notes included
elsewhere in this Annual Report on Form 10-K.

Business Overview



AMETEK's operations are affected by global, regional and industry economic
factors. However, the Company's strategic geographic and industry
diversification, and its mix of products and services, have helped to mitigate
the potential adverse impact of any unfavorable developments in any one industry
or the economy of any single country on its consolidated operating results. In
2021, the Company posted record sales, operating income, operating margins, net
income, diluted earnings per share, backlog, and orders. The Company's record
backlog, contributions from recent acquisitions, and continued focus on and
implementation of Operating Excellence initiatives, had a positive impact on
2021 results. The Company also benefited from its strategic initiatives under
AMETEK's four key strategies: Operational Excellence, Strategic Acquisitions,
Global & Market Expansion and New Products.

Highlights of 2021 were:



•Net sales for 2021 were a record $5,546.5 million, an increase of $1,006.5
million or 22.2%, compared with net sales of $4,540.0 million in 2020. The
increase in net sales for 2021 was due to a 15% organic sales increase, a 7%
increase from acquisitions, and a favorable 1% effect of foreign currency
translation, partially offset by an unfavorable divestiture impact.

•Net income for 2021 was a record $990.1 million, an increase of $117.7 million or 13.5%, compared with $872.4 million in 2020.

•Diluted earnings per share for 2021 were a record $4.25, an increase of $0.48 or 12.7%, compared with $3.77 per diluted share in 2020.



•Orders for 2021 were a record $6,474.4 million, an increase of $1,850.0 million
or 40.0%, compared with $4,624.4 million in 2020. The increase in orders was due
to a 26% organic order increase, a favorable 15% from acquisitions, partially
offset by an unfavorable 1% effect of foreign currency translation. As a result,
the Company's backlog of unfilled orders at December 31, 2021 was a record
$2,730.1 million.

•During 2021, the Company spent $1,959.2 million in cash, net of cash acquired, to purchase six businesses:

•In February 2021, AMETEK acquired EGS Automation ("EGS"), a designer and manufacturer of highly engineered, customized robotic solutions used in critical applications for the medical, food and beverage, and general industrial markets.

•In March 2021, AMETEK acquired Magnetrol International ("Magnetrol"), a leading provider of level and flow control solutions for challenging process applications across a diverse set of end markets including medical, pharmaceutical, oil and gas, food and beverage, and general industrial.


                                       23

--------------------------------------------------------------------------------

Table of Contents

•In March 2021, AMETEK acquired Crank Software, a leading provider of embedded graphical user interface software and services.



•In April 2021, AMETEK acquired NSI-MI Technologies ("NSI-MI"), a leading
provider of radio frequency and microwave test and measurement systems for niche
applications across the aerospace, defense, automotive, wireless communications,
and research markets.

•In April 2021, AMETEK acquired Abaco Systems, Inc. ("Abaco"), specializing in
open-architecture computing and electronic systems for aerospace, defense, and
specialized industrial markets and is a leading provider of mission critical
embedded computing systems.

•In November 2021, AMETEK acquired Alphasense, a leading provider of gas and
particulate sensors for use in environmental, health and safety, and air quality
applications.

•Cash flow provided by operating activities for 2021 was $1,160.5 million. Free
cash flow (cash flow provided by operating activities less capital expenditures)
was $1,049.8 million in 2021.

•EBITDA (earnings before interest, income taxes, depreciation, and amortization) was a record $1,594.3 million in 2021, compared with $1,421.6 million in 2020.



•The Company continued its emphasis on investment in research, development and
engineering, spending $299.6 million in 2021. Sales from products introduced in
the past three years were $1,244.0 million.

Impact of COVID-19 Pandemic on our Business



The COVID-19 pandemic resulted in significant global economic disruption and had
an adverse impact on our financial results throughout 2020. As the global
economy has begun to recover, we eliminated certain of the temporary cost saving
actions put in place in 2020, but continue to closely monitor fixed costs,
capital expenditure plans, inventory, and capital resources to respond to
changing conditions and to ensure we have the resources to meet our future
needs. We have experienced sequential improvement in our financial results since
the third quarter of 2020, and this trend has continued throughout 2021. The
current economic environment in which we operate is characterized by increased
material cost inflation, logistics challenges, labor availability issues, and
component part shortages. As we move into 2022, we continue to monitor and
closely manage through these conditions and have taken steps to mitigate the
impacts of the challenging economic environment.

We are closely tracking developments regarding vaccine mandates. Until it was
prohibited by a federal court order in December 2021, we had taken steps to
comply with the federal contractor vaccine mandate, requiring employees in our
U.S. workforce to be fully vaccinated against COVID-19 by January 18, 2022,
except in limited circumstances. Although the federal contractor mandate has
been temporarily suspended, pending the outcome of an appeal, we continue to
encourage all employees to be vaccinated, including booster shots. If the
mandate is reinstated, or new mandates implemented, it is uncertain to what
extent compliance with such vaccine mandates may result in workforce attrition.

Our top priority during this pandemic is the health and safety of our employees.
All global manufacturing facilities remained fully operational during 2021 and
continue to operate with safety protocols in place to ensure the health and
safety of our employees and communities. We will continue to evaluate the nature
and extent of future impacts of the COVID-19 pandemic on its business. Please
refer to "Risk Factors", Part I, Item 1A of this Form 10-K for more information.


                                       24

--------------------------------------------------------------------------------

Table of Contents

Results of Operations



The following table sets forth net sales and income by reportable segment and on
a consolidated basis:

                                                                          Year Ended December 31,
                                                               2021                 2020                 2019
                                                                               (In thousands)
Net sales:
Electronic Instruments                                    $ 3,763,758          $ 2,989,928          $ 3,322,881
Electromechanical                                           1,782,756            1,550,101            1,835,676
Consolidated net sales                                    $ 5,546,514          $ 4,540,029          $ 5,158,557
Operating income and income before income taxes:
Segment operating income:
Electronic Instruments                                    $   958,183          $   770,620          $   865,307
Electromechanical                                             437,378              324,962              387,931
Total segment operating income                              1,395,561            1,095,582            1,253,238
Corporate administrative expenses                             (86,891)             (67,698)             (75,858)
Consolidated operating income                               1,308,670            1,027,884            1,177,380
Interest expense                                              (80,381)             (86,062)             (88,481)
Other (expense) income, net                                    (5,119)             140,487              (19,151)
Consolidated income before income taxes                   $ 1,223,170

$ 1,082,309 $ 1,069,748

______________________



The following "Results of Operations of the year ended December 31, 2021
compared with the year ended December 31, 2020" section presents an analysis of
the Company's consolidated operating results displayed in the Consolidated
Statement of Income. A discussion regarding our financial condition and results
of operations for the year ended December 31, 2020 compared to the year ended
December 31, 2019 can be found under Item 7 in our Annual Report on Form 10-K
for the fiscal year ended December 31, 2020, filed with the Securities and
Exchange Commission on February 18, 2021.

Results of Operations for the year ended December 31, 2021 compared with the year ended December 31, 2020

Net sales for 2021 were a record $5,546.5 million, an increase of $1,006.5 million or 22.2%, compared with net sales of $4,540.0 million in 2020. The increase in net sales for 2021 was due to a 15% organic sales increase, a 7% increase from acquisitions, and a favorable 1% effect of foreign currency translation, partially offset by an unfavorable divestiture impact. EIG net sales were $3,763.8 million in 2021, an increase of 25.9%, compared with $2,989.9 million in 2020. EMG net sales were $1,782.8 million in 2021, an increase of 15.0%, compared with $1,550.1 million in 2020.



Total international sales for 2021 were a record $2,745.6 million or 49.5% of
net sales, an increase of $535.7 million or 24.2%, compared with international
sales of $2,209.9 million or 48.7% of net sales in 2020. The increase in
international sales was primarily driven by strong demand in Europe and Asia as
well as contributions from recent acquisitions. Export shipments from the United
States, which are included in total international sales, were $1,475.6 million
in 2021, an increase of $279.2 million or 23.3%, compared with $1,196.4 million
in 2020.

Orders for 2021 were a record $6,474.4 million, an increase of $1,850.0 million
or 40.0% compared with $4,624.4 million in 2020. The increase in orders was due
to a 26% organic order increase, a favorable 15% from acquisitions, partially
offset by an unfavorable 1% effect of foreign currency translation. The
Company's backlog of unfilled orders at December 31, 2021 was a record
$2,730.1 million, an increase of $927.9 million or 51.5%, compared with $1,802.2
million at December 31, 2020.
                                       25

--------------------------------------------------------------------------------

Table of Contents



Segment operating income for 2021 was $1,395.6 million, an increase of $300.0
million or 27.4%, compared with segment operating income of $1,095.6 million in
2020. Segment operating income, as a percentage of net sales, increased to 25.2%
in 2021, compared with 24.1% in 2020. The Company recorded 2020 realignment
costs of $43.7 million in response to the impact of a weak global economy as a
result of the COVID-19 pandemic. The 2020 realignment costs were composed of
$35.3 million in severance costs for a reduction of workforce and $8.4 million
of asset write-downs, primarily inventory, which decreased margins by 100 basis
points. Segment operating income and segment operating margins were positively
impacted in 2021 by the increase in net sales discussed above as well as the
Company's Operational Excellence initiatives, including ongoing savings from the
2020 realignment actions.

Cost of sales for 2021 was $3,633.9 million or 65.5% of net sales, an increase
of $637.4 million or 21.3%, compared with $2,996.5 million or 66.0% of net sales
for 2020. The cost of sales increase was primarily due to the net sales increase
discussed above. The 2020 cost of sales included the realignment costs discussed
above.

Selling, general and administrative expenses for 2021 were $603.9 million or
10.9% of net sales, an increase of $88.3 million or 17.1%, compared with $515.6
million or 11.4% of net sales in 2020. Selling, general and administrative
expenses increased primarily due to the increase in net sales discussed above.

Consolidated operating income was a record $1,308.7 million or a record 23.6% of
net sales for 2021, an increase of $280.8 million or 27.3%, compared with
$1,027.9 million or 22.6% of net sales in 2020. The consolidated operating
income and operating income margins were positively impacted in 2021 by the
increase in net sales discussed above as well as the benefits of the Company's
Operational Excellence initiatives. The 2021 acquisitions of Abaco, Magnetrol,
NSI-MI, Crank Software, EGS, and Alphasense diluted operating margins by 110
basis points. Excluding the acquisitions, operating income margins would have
been 24.7% for 2021. The consolidated operating income margins were negatively
impacted by 100 basis points in 2020 due to the realignment costs discussed
above.

Other expense, net was $5.1 million for 2021, compared with $140.5 million of
other income in 2020, a change of $145.6 million. In March 2020, the Company
completed the sale of its Reading Alloys business ("Reading") to Kymera
International for net proceeds of $245.3 million in cash. The sale resulted in a
pre-tax gain of $141.0 million.

The effective tax rate for 2021 was 19.1%, compared with 19.4% in 2020. See Note
9 to the Consolidated Financial Statements included in Part II, Item 8 of this
Annual Report on Form 10-K for further details.

Net income for 2021 was a record $990.1 million, an increase of $117.7 million
or 13.5%, compared with $872.4 million in 2020. The net of tax gain of $109.6
million on the sale of Reading and net of tax expense of $33.6 million on the
2020 realignment costs are included in net income in 2020.

Diluted earnings per share for 2021 were a record $4.25, an increase of $0.48 or
12.7%, compared with $3.77 per diluted share in 2020. The net of tax gain of
$0.47 per diluted share on the sale of Reading and net of tax expense of $0.15
per diluted share on the 2020 realignment costs are included in diluted earnings
per share in 2020.

Segment Results

EIG's net sales totaled $3,763.8 million for 2021, an increase of $773.9 million
or 25.9%, compared with $2,989.9 million in 2020. The net sales increase was due
to a 14% organic sales increase, an 11% increase from acquisitions, and a
favorable 1% effect of foreign currency translation.

EIG's operating income was $958.2 million for 2021, an increase of $187.6
million or 24.3%, compared with $770.6 million in 2020. EIG's operating margins
were 25.5% of net sales for 2021, compared with 25.8% of net sales in 2020.
EIG's operating income and operating margins in 2021 were positively impacted by
the sales increase discussed above as well as the Company's Operational
Excellence initiatives. The 2021 acquisitions of Abaco, Magnetrol, NSI-MI, Crank
Software, and Alphasense diluted operating margins by 180 basis points.
Excluding the
                                       26

--------------------------------------------------------------------------------

Table of Contents

acquisitions, EIG operating margins would have been 27.3% for 2021. EIG's operating margins were negatively impacted in 2020 by 70 basis points due to the 2020 realignment costs discussed above.



EMG's net sales totaled $1,782.8 million for 2021, an increase of $232.7 million
or 15.0%, compared with $1,550.1 million in 2020. The net sales increase was due
to a 15% organic sales increase, a favorable 1% effect of foreign currency
translations, partially offset by an unfavorable 1% impact from the Reading
divestiture.

EMG's operating income was $437.4 million for 2021, an increase of $112.4
million or 34.6%, compared with $325.0 million in 2020. EMG's operating margins
were 24.5% of net sales for 2021, compared with 21.0% of net sales in 2020.
EMG's operating income and operating margins in 2021 were positively impacted by
the sales increase discussed above as well as the Company's Operational
Excellence initiatives. EMG's 2020 operating margins were negatively impacted by
130 basis points due to the 2020 realignment costs discussed above.

Liquidity and Capital Resources



Cash provided by operating activities totaled $1,160.5 million in 2021, a
decrease of $120.5 million or 9.4%, compared with $1,281.0 million in 2020. The
decrease in cash provided by operating activities for 2021 was primarily due to
higher working capital requirements, partially offset by higher net income, net
of the gain on the sale of the Reading business in 2020.

Free cash flow (cash flow provided by operating activities less capital
expenditures) was $1,049.8 million in 2021, compared with $1,206.8 million in
2020. EBITDA (earnings before interest, income taxes, depreciation and
amortization) was a record $1,594.3 million in 2021, compared with $1,421.6
million in 2020. Free cash flow and EBITDA are presented because the Company is
aware that they are measures used by third parties in evaluating the Company.
(See "Non-GAAP Financial Measures" for a reconciliation of U.S. GAAP measures to
comparable non-GAAP measures).

Cash used by investing activities totaled $2,055.8 million in 2021, compared
with cash provided by investing activities of $61.6 million in 2020. In 2021,
the Company paid $1,959.2 million, net of cash acquired, to purchase Abaco
Systems, Magnetrol International, NSI-MI Technologies, Crank Software, EGS
Automation, and Alphasense compared to $116.5 million to acquire IntelliPower in
2020. In 2020, the Company received proceeds of $245.3 million from the sale of
its Reading business. Additions to property, plant and equipment totaled $110.7
million in 2021, compared with $74.2 million in 2020.

Cash provided by financing activities totaled $39.3 million in 2021, compared
with $539.4 million of cash used by financing activities in 2020. At
December 31, 2021, total debt, net was $2,544.2 million, compared with $2,413.7
million at December 31, 2020. In 2021, total borrowings increased by $183.9
million, driven by the 2021 acquisitions, compared with a decrease of $430.9
million in 2020. At December 31, 2021, the Company had available borrowing
capacity of $2,447.5 million under its revolving credit facility and term loan,
including the $500 million accordion feature.

On April 26, 2021, the Company along with certain of its foreign subsidiaries
amended its credit agreement dated as of September 22, 2011, as amended and
restated as of March 10, 2016 and as further amended and restated as of October
30, 2018, with the lenders, JPMorgan Chase Bank, N.A., as Administrative Agent
and Bank of America, N.A., PNC Bank, National Association, Trust Bank and Wells
Fargo Bank, National Association, as Co-Syndication Agents. The credit agreement
amends the Company's existing revolving credit facility to add a new five-year,
delayed draw, term loan for up to $800 million. The credit agreement places
certain restrictions on allowable additional indebtedness. In November 2021, the
Company further amended the Credit Agreement to address the cessation of LIBOR
on certain currencies. At December 31, 2021, the Company had $150.0 million
outstanding on the term loan.

In the fourth quarter of 2021, 55 million Swiss franc ($59.7 million) 2.44%
senior note matured and was paid. In the third quarter of 2020, an 80 million
British pound ($102.9 million) 4.68% senior note matured and was paid. The
debt-to-capital ratio was 27.0% at December 31, 2021, compared with 28.9% at
December 31, 2020. The net
                                       27

--------------------------------------------------------------------------------

Table of Contents



debt-to-capital ratio (total debt, net less cash and cash equivalents divided by
the sum of net debt and stockholders' equity) was 24.2% at December 31, 2021,
compared with 16.8% at December 31, 2020. The net debt-to-capital ratio is
presented because the Company is aware that this measure is used by third
parties in evaluating the Company. (See "Non-GAAP Financial Measures" for a
reconciliation of U.S. GAAP measures to comparable non-GAAP measures).

In 2021, the Company repurchased approximately 113,000 shares of its common
stock for $14.7 million, compared with $4.7 million used for repurchases of
approximately 55,000 shares in 2020. At December 31, 2021, $469.7 million was
available under the Company's Board of Directors authorization for future share
repurchases.

Additional financing activities for 2021 included cash dividends paid of $184.6
million, compared with $165.0 million in 2020. On February 11, 2021, the
Company's Board of Directors approved an 11% increase in the quarterly cash
dividend on the Company's common stock to $0.20 per common share from $0.18 per
common share. Proceeds from the exercise of employee stock options were $60.3
million in 2021, compared with $64.9 million in 2020.

As a result of all of the Company's cash flow activities in 2021, cash and cash
equivalents at December 31, 2021 totaled $346.8 million, compared with $1,212.8
million at December 31, 2020. At December 31, 2021, the Company had $334.0
million in cash outside the United States, compared with $344.0 million at
December 31, 2020. The Company utilizes this cash to fund its international
operations, as well as to acquire international businesses. The Company is in
compliance with all covenants, including financial covenants, for all of its
debt agreements. The Company believes it has sufficient cash-generating
capabilities from domestic and unrestricted foreign sources, available credit
facilities and access to long-term capital funds to enable it to meet its
operating needs and contractual obligations for the foreseeable future.

Subsequent Event

Effective February 9, 2022, the Company's Board of Directors approved a 10% increase in the quarterly cash dividend on the Company's common stock to $0.22 per common share from $0.20 per common share.

Contractual Obligations and Other Commitments

Material contractual obligations arising in the normal course of business primarily consist of purchase obligations, long-term debt and related interest payments, and leases. See Note 10 to the Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for more information on the nature and timing of debt obligations.



Leases expire over a range of years from 2022 to 2032, except for a single land
lease with 62 years remaining. Most of the leases contain renewal or purchase
options, subject to various terms and conditions. See Note 14 to the
Consolidated Financial Statements included in Part II, Item 8 of this Annual
Report on Form 10-K for more information on the nature and timing of lease
obligations.

Purchase obligations primarily consist of contractual commitments to purchase
certain inventories at fixed prices. At December 31, 2021, the Company had
$840.4 million of purchase obligations due within one year and $50.5 million of
purchase obligations due in more than one year.

The Company has standby letters of credit and surety bonds of $56.2 million
related to performance and payment guarantees at December 31, 2021. Based on
experience with these arrangements, the Company believes that any obligations
that may arise will not be material to its financial position.


                                       28

--------------------------------------------------------------------------------

Table of Contents

Non-GAAP Financial Measures



EBITDA represents earnings before interest, income taxes, depreciation and
amortization. EBITDA is presented because the Company is aware that it is used
by rating agencies, securities analysts, investors and other parties in
evaluating the Company. It should not be considered, however, as an alternative
to operating income as an indicator of the Company's operating performance or as
an alternative to cash flows as a measure of the Company's overall liquidity as
presented in the Company's consolidated financial statements. Furthermore,
EBITDA measures shown for the Company may not be comparable to similarly titled
measures used by other companies. The following table presents the
reconciliation of net income reported in accordance with U.S. generally accepted
accounting principles ("GAAP") to EBITDA:

                             Year Ended December 31,
                       2021           2020           2019
                                  (In millions)
Net income          $   990.1      $   872.4      $   861.3
Add (deduct):
Interest expense         80.4           86.1           88.5
Interest income          (1.4)          (2.1)          (4.0)
Income taxes            233.1          209.9          208.5
Depreciation            108.5          101.3          101.4
Amortization            183.6          154.0          132.6
Total adjustments       604.2          549.2          527.0
EBITDA              $ 1,594.3      $ 1,421.6      $ 1,388.3


Free cash flow represents cash flow from operating activities less capital
expenditures. Free cash flow is presented because the Company is aware that it
is used by rating agencies, securities analysts, investors and other parties in
evaluating the Company. The following table presents the reconciliation of cash
flow from operating activities reported in accordance with U.S. GAAP to free
cash flow:

                                                   Year Ended December 31,
                                             2021           2020           2019
                                                        (In millions)
Cash provided by operating activities     $ 1,160.5      $ 1,281.0      $ 1,114.4
Deduct: Capital expenditures                 (110.7)         (74.2)        (102.3)
Free cash flow                            $ 1,049.8      $ 1,206.8      $ 1,012.1


Net debt represents total debt, net minus cash and cash equivalents. Net debt is
presented because the Company is aware that it is used by rating agencies,
securities analysts, investors and other parties in evaluating the Company. The
following table presents the reconciliation of total debt, net reported in
accordance with U.S. GAAP to net debt:

                                                              December 31,
                                                          2021            2020
                                                             (In millions)
Total debt, net                                       $ 2,544.2       $ 2,413.7
Less: Cash and cash equivalents                          (346.8)       (1,212.8)
Net debt                                                2,197.4         1,200.9
Stockholders' equity                                    6,871.9         5,949.3

Capitalization (net debt plus stockholders' equity) $ 9,069.3 $ 7,150.2 Net debt as a percentage of capitalization

                 24.2  %         16.8  %



                                       29

--------------------------------------------------------------------------------


  Table of Contents

Internal Reinvestment

Capital Expenditures

Capital expenditures were $110.7 million or 2.0% of net sales in 2021, compared
with $74.2 million or 1.6% of net sales in 2020. In 2021, approximately 63% of
capital expenditures were for improvements to existing equipment or additional
equipment to increase productivity and expand capacity. Capital expenditures in
2022 are expected to be approximately 2% of net sales, with a continued emphasis
on spending to improve productivity.

Research, Development and Engineering



The Company is committed to, and has consistently invested in, research,
development and engineering activities to design and develop new and improved
products and solutions. Research, development and engineering costs before
customer reimbursement were $299.6 million in 2021, $246.2 million in 2020 and
$260.3 million in 2019. These amounts included research and development expenses
of $194.2 million, $158.9 million and $161.9 million in 2021, 2020, and 2019,
respectively. All such expenditures were directed toward the development of new
products and solutions and the improvement of existing products and solutions.

Environmental Matters



Information with respect to environmental matters is set forth in Note 13 to the
Consolidated Financial Statements included in Part II, Item 8 of this Annual
Report on Form 10-K.


Critical Accounting Policies and Estimates



Critical accounting policies are those policies that can have a significant
impact on the presentation of the Company's financial condition and results of
operations and that require the use of complex and subjective estimates based on
the Company's historical experience and management's judgment. Because of the
uncertainty inherent in such estimates, actual results may differ materially
from the estimates used. Below are the policies used in preparing the Company's
financial statements that management believes are the most dependent upon the
application of estimates and assumptions. A complete list of the Company's
significant accounting policies is in Note 1 to the Consolidated Financial
Statements included in Part II, Item 8 of this Annual Report on Form 10-K.

•Business Combinations. The Company allocates the purchase price of an acquired
company, including when applicable, the acquisition date fair value of
contingent consideration between tangible and intangible assets acquired and
liabilities assumed from the acquired business based on their estimated fair
values, with the residual of the purchase price recorded as goodwill. Third
party appraisal firms and other consultants are engaged to assist management in
determining the fair values of certain assets acquired and liabilities assumed.
Estimating fair values requires significant judgments, estimates and
assumptions, including but not limited to: discount rates, future cash flows and
the economic lives of trade names, technology, and customer relationships. These
estimates are based on historical experience and information obtained from the
management of the acquired companies and are inherently uncertain.

•Goodwill and Other Intangible Assets. Goodwill and other intangible assets with
indefinite lives, primarily trademarks and trade names, are not amortized;
rather, they are tested for impairment at least annually. The Company can elect
to perform a qualitative analysis to determine if it is more likely than not
that the fair values of its reporting units are less than the respective
carrying values of those reporting units. The Company elected to bypass
performing the qualitative screen and performed the quantitative analysis of the
goodwill impairment test in the current year. The Company may elect to perform
the qualitative analysis in future periods.

The Company principally relies on a discounted cash flow analysis to determine
the fair value of each reporting unit, which considers forecasted cash flows
discounted at an appropriate discount rate. The
                                       30

--------------------------------------------------------------------------------

Table of Contents



Company believes that market participants would use a discounted cash flow
analysis to estimate the fair value of its reporting units in a sale
transaction. The annual goodwill impairment test requires the Company to make a
number of assumptions and estimates concerning future levels of revenue growth,
operating margins, depreciation, amortization and working capital requirements,
which are based on the Company's long-range plan and are considered level 3
inputs. The Company's long-range plan is updated as part of its annual planning
process and is reviewed and approved by management. The discount rate is an
estimate of the overall after-tax rate of return required by a market
participant whose weighted average cost of capital includes both equity and
debt, including a risk premium. While the Company uses the best available
information to prepare its cash flow and discount rate assumptions, actual
future cash flows or market conditions could differ significantly resulting in
future impairment charges related to recorded goodwill balances. While there are
always changes in assumptions to reflect changing business and market
conditions, the Company's overall methodology and the population of assumptions
used have remained unchanged. In order to evaluate the sensitivity of the
goodwill impairment test to changes in the fair value calculations, the Company
applied a hypothetical 10% decrease in fair values of each reporting unit. The
2021 results (expressed as a percentage of carrying value for the respective
reporting unit) showed that, despite the hypothetical 10% decrease in fair
value, the fair values of the Company's reporting units still exceeded their
respective carrying values by 118% to 534%.

The impairment test for indefinite-lived intangibles other than goodwill
(primarily trademarks and trade names) consists of a comparison of the estimated
fair value of the indefinite-lived intangible asset to the carrying value of the
asset as of the impairment testing date. The Company can elect to perform a
qualitative analysis to determine if it is more likely than not that the fair
values of its indefinite-lived intangible assets are less than the respective
carrying values of those assets. The Company elected to bypass performing the
qualitative screen. The Company may elect to perform the qualitative analysis in
future periods. The Company estimates the fair value of its indefinite-lived
intangibles using the relief from royalty method using level 3 inputs, which is
a widely used valuation technique for such assets. The fair value derived from
the relief from royalty method is determined by applying a royalty rate to a
projection of net revenues discounted using an appropriate discount rate. Each
royalty rate is determined based on the profitability of the trade name to which
it relates and observed market royalty rates. Certain impairment models have
discount rates calculated based on a debt/equity cost of capital. While the
Company uses the best available information to prepare its cash flow and
discount rate assumptions, actual future cash flows or market conditions could
differ significantly resulting in future impairment charges related to recorded
intangible balances. While there are always changes in assumptions to reflect
changing business and market conditions, the Company's overall methodology and
the population of assumptions used have remained unchanged.

The Company's acquisitions have generally included a significant goodwill
component and the Company expects to continue to make acquisitions. At
December 31, 2021, goodwill and other indefinite-lived intangible assets totaled
$6,113.1 million or 51.4% of the Company's total assets. The Company completed
its required annual impairment tests in the fourth quarter of 2021 and
determined that the carrying values of the Company's goodwill and
indefinite-lived intangibles were not impaired. There can be no assurance that
goodwill or indefinite-lived intangibles impairment will not occur in the
future.

•Pensions. The Company has U.S. and foreign defined benefit and defined
contribution pension plans. The most significant elements in determining the
Company's pension income or expense are the assumed pension liability discount
rate and the expected return on plan assets. The pension discount rate reflects
the current interest rate at which the pension liabilities could be settled at
the valuation date. At the end of each year, the Company determines the assumed
discount rate to be used to discount plan liabilities. In estimating this rate
for 2021, the Company considered rates of return on high-quality, fixed-income
investments that have maturities consistent with the anticipated funding
requirements of the plan. In estimating the U.S. and foreign discount rates, the
Company's actuaries developed a customized discount rate appropriate to the
plans' projected benefit cash flow based on yields derived from a database of
long-term bonds at consistent maturity dates. The Company determines the
expected long-term rate of return based primarily on its expectation of future
returns for the pension plans' investments. Additionally, the
                                       31

--------------------------------------------------------------------------------

Table of Contents

Company considers historical returns on comparable fixed-income and equity investments and adjusts its estimate as deemed appropriate.



•Income Taxes. The process of providing for income taxes and determining the
related balance sheet accounts requires management to assess uncertainties, make
judgments regarding outcomes and utilize estimates. The Company conducts a broad
range of operations around the world and is therefore subject to complex tax
regulations in numerous international taxing jurisdictions, resulting at times
in tax audits, disputes and potential litigation, the outcome of which is
uncertain. Management must make judgments currently about such uncertainties and
determine estimates of the Company's tax assets and liabilities. To the extent
the final outcome differs, future adjustments to the Company's tax assets and
liabilities may be necessary.

The Company assesses the realizability of its deferred tax assets, taking into
consideration the Company's forecast of future taxable income, available net
operating loss carryforwards and available tax planning strategies that could be
implemented to realize the deferred tax assets. Based on this assessment,
management must evaluate the need for, and the amount of, valuation allowances
against the Company's deferred tax assets. To the extent facts and circumstances
change in the future, adjustments to the valuation allowances may be required.

The Company assesses the uncertainty in its tax positions, by applying a minimum
recognition threshold which a tax position is required to meet before a tax
benefit is recognized in the financial statements. Once the minimum threshold is
met, using a more likely than not standard, a series of probability estimates is
made for each item to properly measure and record a tax benefit. The tax benefit
recorded is generally equal to the highest probable outcome that is more than
50% likely to be realized after full disclosure and resolution of a tax
examination. The underlying probabilities are determined based on the best
available objective evidence such as recent tax audit outcomes, published
guidance, external expert opinion, or by analogy to the outcome of similar
issues in the past. There can be no assurance that these estimates will
ultimately be realized given continuous changes in tax policy, legislation and
audit practice. The Company recognizes interest and penalties accrued related to
uncertain tax positions in income tax expense.

Recent Accounting Pronouncements

See Note 2, Recent Accounting Pronouncements, to the Company's Consolidated Financial Statements included in Part II, Item 8 of this Annual Report on Form 10-K for information regarding recently issued accounting pronouncements.

Forward-Looking Information



Certain matters discussed in this Form 10-K are "forward-looking statements" as
defined in the Private Securities Litigation Reform Act of 1995 ("PSLRA"), which
involve risk and uncertainties that exist in the Company's operations and
business environment and can be affected by inaccurate assumptions, or by known
or unknown risks and uncertainties. Many such factors will be important in
determining the Company's actual future results. The Company wishes to take
advantage of the "safe harbor" provisions of the PSLRA by cautioning readers
that numerous important factors in some cases have caused, and in the future
could cause, the Company's actual results to differ materially from those
expressed in any forward-looking statements made by, or on behalf of, the
Company. Some, but not all, of the factors or uncertainties that could cause
actual results to differ from present expectations are set forth above and under
Item 1A. Risk Factors. The Company undertakes no obligation to publicly update
any forward-looking statements, whether as a result of new information,
subsequent events or otherwise, unless required by the securities laws to do so.
                                       32

--------------------------------------------------------------------------------

Table of Contents

© Edgar Online, source Glimpses